About
NIDO (Boston, MA) is a medical device company developing SEPIA, an innovative solution for epicardial ablation of ventricular tachycardia (VT), based on technology developed at Boston Children's Hospital. It has been co-founded by Pedro del Nido, Chairman of Cardiovascular Surgery and Professor at Harvard Medical School, and Nikolay Vasilyev, Medical Director for Surgicals Portfolio at Pfizer. SEPIA will allow real-time visualization of the epicardial surface and provide angle and force control to an ablation catheter. Ultimately, it will reduce complications and improve ablation efficiency, leading to decrease recurrence of VT.
Technologies
Cloudflare DNS
CloudFlare Hosting
Google Tag Manager
Mobile Friendly
Remote
Keywords
tricuspid valve repair
mitral valve repair
epicardial rf ablation
beating heart surgery
pacer lead extraction
endocardial rf ablation
minimally invasive cardiac surgery
atrial septal defect repair
intracardiac diagnostic imaging
Company Information
-
Employees 11
-
Founded 2015
-
Total Funding $4328530
Location
Boston, Massachusetts, United States, 02116
